Efficacy and safety of afatinib in Chinese patients with EGFR-mutated metastatic non-small-cell lung cancer (NSCLC) previously responsive to first-generation tyrosine-kinase inhibitors (TKI) and chemotherapy: comparison with historical cohort using erlotinib.

Background: Afaitnib has shown anti-tumor activity against metastatic EGFR-mutated NSCLC after prior failure to first generation EGFR-TKI and chemotherapy. We prospectively evaluated the efficacy and safety of afatinib in Chinese patients who previously failed first-generation TKI and chemotherapy under a compassionate use program (CUP) and compared to the erlotinib cohort.

Methods: Patients who suffered from metastatic EGFR-mutated NSCLC previously responsive to first-generation TKI and chemotherapy received afatinib until progression, loss of clinical benefits or intolerable toxicity.

Comparing the effects of rehabilitation swallowing therapy vs. functional neuromuscular electrical stimulation therapy in an encephalitis patient: a case study.

A 49-year-old man with pharyngeal dysphagia after encephalitis is presented in this case study. Sixteen months earlier the patient experienced a sudden severe fever which resulted in encephalitis, leading to liquid dysphagia. Despite receiving an initial treatment of swallowing therapy, the patient's liquid dysphagia did not improve.

The validation of the Chinese version of the Swallow Quality-of-Life Questionnaire (SWAL-QOL) using exploratory and confirmatory factor analysis.

The aim of this work was to study the psychometric properties of the Chinese version of the Swallow Quality-of-Life Questionnaire (CSWAL-QOL) validated in the Hong Kong Chinese-speaking population. With convenience sampling, a cross-sectional survey was launched to evaluate the validity and reliability of the CSWAL-QOL. One hundred subjects with swallowing problems were recruited to evaluate the construct validity and internal consistency, and 20 subjects were recruited for the test-retest reliability.